Dr Chloe Pek Sang Tang is an accomplished clinical haematologist with internationally recognised expertise in lymphoproliferative disorders. She obtained her medical degree at The University of Melbourne in 2007 before completing further advanced haematology training in 2015, at the leading centres of St Vincent’s Hospital Melbourne, Alfred Hospital, Monash Medical Centre and Peter MacCallum Cancer Centre. Subsequently, she embarked on a PhD on Chronic Lymphocytic Leukaemia (CLL) under the tutelage of Professor Constantine Tam.
In 2019, Chloe undertook a prestigious 12-month fellowship at the University of Oxford’s Molecular Diagnostic Centre with Professor Anna Schuh. This has culminated in her position as leader of the writing task force on behalf of the British Society of Haematology and UK CLL forum for national management guidelines for CLL. Her particular clinical interest using ctDNA to guide treatment for lymphoma is evidenced by her membership on the esteemed Precision Medicine for Aggressive Lymphoma (PMAL) UK consortium. She is passionate about clinical research and has published extensively in top-tier haematology journals including The Lancet.
Chloe is adept at management across the entire spectrum of haematological disorders and also holds a clinical appointment at the Alfred Hospital. Her overarching ethos is to provide individualised, patient-centred care through promotion of precision medicine using cutting-edge molecular techniques. Chloe is fluent in Mandarin, Cantonese and Malay.